The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services globally to companies within the pharmaceutical and biotech sectors.
The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS technology (IVRS/IXRS) through to commercial-scale manufacture and companion diagnostic development.
Only Almac can combine the expertise, from our specialised teams, to provide you with the right service solutions to help you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation.
Headquartered out of the UK (Northern Ireland), with offices and facilities in Scotland, England, the US (Pennsylvania, North Carolina & California) and Asia (Singapore and Japan), we employ in excess of 4,000 employees worldwide.
With over 40 years’ of experience, we work across all therapeutic areas for a wide range of organisations.
Through our continual investment in the development of our state of the art services; from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures we are always there to support you across the product development lifecycle.